ClearSight Therapeutics, Inc.

ClearSight Therapeutics is dedicated to enhancing patient outcomes by developing innovative over-the-counter (OTC) products for individuals suffering from Dry Eye Disease, Contact Lens Rewetting, and Acute Infectious Conjunctivitis (commonly known as “Pink Eye”). We leverage our proprietary dual-action formulation, which combines an artificial tear with a potent antimicrobial biopolymer. Our products will be the first in their class to address biofilm complications associated with Dry Eye and extended contact lens wear. Furthermore, our Pink Eye treatment will be the first OTC medication able to treat viral pink eye, which accounts for approximately 80% of cases.